MUMBAI, India, Aug. 31 -- Intellectual Property India has published a patent application (202617081651 A) filed by Asgard Therapeutics Ab on July 02, 2026, for Rna-Based Strategies For Dendritic Cell Reprogramming And Uses Thereof.
Inventors include Rosa, Fbio Alexandre Fiza; Arh, Nejc; Vaz, Beatriz Loureno; Pereira, Filipe Application Number; and Xie, Lihan.
The application for the patent was published on August 28, 2026, under issue no. 35/2026.
Abstract: The present invention relates to compositions comprising RNAs, uses thereof, and RNA-based gene expression methods for reprogramming cells to type 1 conventional dendritic cells or antigen-presenting cells. The invention further relates to cells, reprogrammed cells, and uses thereof....